Screener
Myriad Genetics MYGN Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
FAQ
- What is Myriad Genetics's accrued expenses?
- Myriad Genetics (MYGN) reported accrued expenses of $39.8M in Q1 2026.
- How has Myriad Genetics's accrued expenses changed year-over-year?
- Myriad Genetics's accrued expenses decreased by 7.4% year-over-year, from $43M to $39.8M.
- What is the long-term trend for Myriad Genetics's accrued expenses?
- Over 5 years (2020 to 2025), Myriad Genetics's accrued expenses has grown at a -8.3% compound annual growth rate (CAGR), from $79.1M to $51.2M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Myriad Genetics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude